Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Cluster-randomized controlled trial for the early promotion of clinic visits for untreated hypertension

Abstract

Despite clear evidence of the benefits of lowering blood pressure among patients with hypertension, the treatment rate remains <40% worldwide. In the present trial, we aimed to investigate the effects of the early promotion of clinic visits among patients with untreated hypertension detected during annual health checkups. This was a worksite-based, parallel group, cluster-randomized trial with blinded outcome assessment. Employees of 152 Japanese supermarket stores found to have untreated hypertension (blood pressure levels ≥ 160/100 mmHg) during health checkups were assigned to an early promotion group (encouraged to visit a clinic in face-to-face interviews and provided with a referral letter to a physician as well as a leaflet) or a control group (received usual care), according to random assignment. The primary outcome was the completion of a clinic visit within 6 months. Odds ratios with 95% confidence intervals for the early promotion group versus the control group were estimated using multilevel logistic regression with random effects of clusters. A total of 273 participants (mean age 50.3 years, 55% women) from 107 stores were assigned to the early promotion group (138 from 55 stores) or control group (135 from 52 stores). During the 6-month follow-up, 47 (34.1%) participants in the early promotion group visited a clinic, as did 26 (19.3%) in the control group (odds ratio 2.33, 95% confidence interval 1.12–4.84, P = 0.024). Early promotion using a referral letter during health checkups significantly increased the number of clinic visits within 6 months completed by participants with untreated hypertension (UMIN000025411).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

References

  1. Staessen JA, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens. 2003;21:1055–76. https://doi.org/10.1097/00004872-200306000-00002.

    Article  CAS  PubMed  Google Scholar 

  2. Blood Pressure Lowering Treatment Trialists’ Collaboration, Turnbull F, Neal B, Pfeffer M, Kostis J, Algert C, et al. Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. J Hypertens. 2007;25:951–8. https://doi.org/10.1097/HJH.0b013e3280bad9b4.

    Article  CAS  Google Scholar 

  3. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:1245. https://doi.org/10.1136/bmj.b1665.

    Article  Google Scholar 

  4. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957–67. https://doi.org/10.1016/S0140-6736(15)01225-8.

    Article  PubMed  Google Scholar 

  5. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control. Circulation. 2016;134:441–50. https://doi.org/10.1161/CIRCULATIONAHA.115.018912.

    Article  PubMed  PubMed Central  Google Scholar 

  6. NCD Risk Factor Collaboration (NCD-RisC). Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet. 2019;394:639–51. https://doi.org/10.1016/S0140-6736(19)31145-6.

    Article  PubMed  PubMed Central  Google Scholar 

  7. The Japanese Society of Hypertension. The Japanese Society of Hypertension Guidelines for the management of hypertension (JSH 2019). Tokyo, Japan: Life Science Publishing Co., Ltd.; 2019.

    Google Scholar 

  8. Satoh A, Arima H, Ohkubo T, Nishi N, Okuda N, Ae R, et al. NIPPON DATA2010 Research Group. Associations of socioeconomic status with prevalence, awareness, treatment, and control of hypertension in a general Japanese population. J Hypertens. 2017;35:401–8. https://doi.org/10.1097/HJH.0000000000001169.

    Article  CAS  PubMed  Google Scholar 

  9. Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42:1235–481.

    Article  PubMed  Google Scholar 

  10. Turin TC, Murakami Y, Miura K, Rumana N, Kita Y, Hayakawa T, et al. NIPPON DATA80/90 Research Group. Hypertension and life expectancy among Japanese: NIPPON DATA80. Hypertens Res. 2012;35:954–8. https://doi.org/10.1038/hr.2012.86.

    Article  PubMed  Google Scholar 

  11. Kobayashi A. Launch of a national mandatory chronic disease prevention program in Japan. Dis Manag Heal Outcomes. 2008;16:217–25. https://doi.org/10.2165/00115677-200816040-00003.

    Article  Google Scholar 

  12. Kuriyama A, Takahashi Y, Tsujimura Y, Miyazaki K, Satoh T, Ikeda S, et al. Predicting failure to follow-up screened high blood pressure in Japan: a cohort study. J Public Health. 2015;37:498–505. https://doi.org/10.1093/pubmed/fdu056.

    Article  Google Scholar 

  13. Ikegami N. Should providers be allowed to extra bill for uncovered services? Debate, resolution, and sequel in Japan. J Health Polit Policy Law. 2006;31:1129–49. https://doi.org/10.1215/03616878-2006-022.

    Article  PubMed  Google Scholar 

  14. Ikegami N, Yoo BK, Hashimoto H, Matsumoto M, Ogata H, Babazono A, et al. Japanese universal health coverage: evolution, achievements, and challenges. Lancet. 2011;378:1106–15. https://doi.org/10.1016/S0140-6736(11)60828-3.

    Article  PubMed  Google Scholar 

  15. Ministry of Health Labour and Welfare. Comprehensive Survey of Living Conditions in Japan, 2016.2017. https://www.mhlw.go.jp/toukei/saikin/hw/k-tyosa/k-tyosa16/. Accessed 9 March 2020.

  16. Hino Y, Kan H, Minami M, Takada M, Shimokubo N, Nagata T, et al. The challenges of occupational health service centers in Japan. Ind Health. 2006;44:140–3. https://doi.org/10.2486/indhealth.44.140.

    Article  PubMed  Google Scholar 

  17. Suka M, Odajima T, Okamoto M, Sumitani M, Nakayama T, Sugimori H. Reading comprehension of health checkup reports and health literacy in Japanese people. Environ Health Prev Med. 2014;19:295–306. https://doi.org/10.1007/s12199-014-0392-8.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Meng L, Zhao D, Pan Y, Ding W, Wei Q, Li H, et al. Validation of Omron HBP-1300 professional blood pressure monitor based on auscultation in children and adults. BMC Cardiovasc Disord. 2016;16:9. https://doi.org/10.1186/s12872-015-0177-z.

    Article  PubMed  PubMed Central  Google Scholar 

  19. White WB, Anwar YA. Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults. Blood Press Monit. 2001;6:107–10.

    Article  CAS  PubMed  Google Scholar 

  20. Erfurt JC, Foote A, Heirich MA. Worksite wellness programs: incremental comparison of screening and referral alone, health education, follow-up counseling, and plant organization. Am J Health Promot. 1991;5:438–48. https://doi.org/10.4278/0890-1171-5.6.438.

    Article  CAS  PubMed  Google Scholar 

  21. Velez R, Anderson L, McFall S, Magruder-Habib K. Improving patient follow-up in incidental screening through referral letters. Arch Intern Med. 1985;145:2184–7. https://doi.org/10.1001/archinte.1985.00360120052008.

    Article  CAS  PubMed  Google Scholar 

  22. Krieger J, Collier C, Song L, Martin D. Linking community-based blood pressure measurement to clinical care: a randomized controlled trial of outreach and tracking by community health workers. Am J Public Health. 1999;89:856–61. https://doi.org/10.2105/ajph.89.6.856.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Jones PK, Jones SL, Katz J. Improving follow-up among hypertensive patients using a health belief model intervention. Arch Intern Med. 1987;147:1557–60. https://doi.org/10.1001/archinte.1987.00370090037007.

    Article  CAS  PubMed  Google Scholar 

  24. Hanai Y, Tabuse Y, Nishikawa A, Aiba O, Tsuboi M, Tsuchiya E, et al. Increase in examination rate for secondary testing due to improved guidance and future issues. Ningen Dock. 2017;32:2012–7.

    Google Scholar 

  25. Ministry of Health Labour and Welfare. Report on regional public health services and health promotion services. https://www.mhlw.go.jp/toukei/saikin/hw/c-hoken/17/dl/gaikyo.pdf. 2017. Accessed 9 Mar 2020.

  26. Goldbeck R. Denial in physical illness. J Psychosom Res. 1997;43:575–93. https://doi.org/10.1016/S0022-3999(97)00168-2.

    Article  CAS  PubMed  Google Scholar 

  27. Jokisalo E, Kumpusalo E, Enlund H, Takala J. Patients’ perceived problems with hypertension and attitudes towards medical treatment. J Hum Hypertens. 2001;15:755–61. https://doi.org/10.1038/sj.jhh.1001276.

    Article  CAS  PubMed  Google Scholar 

  28. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Clinical inertia. Ann Intern Med. 2001;135:825–34. https://doi.org/10.7326/0003-4819-135-9-200111060-00012.

    Article  CAS  PubMed  Google Scholar 

  29. Josiah Willock R, Miller JB, Mohyi M, Abuzaanona A, Muminovic M, Levy PD. Therapeutic inertia and treatment intensification. Curr Hypertens Rep. 2018;20:4. https://doi.org/10.1007/s11906-018-0802-1.

    Article  CAS  PubMed  Google Scholar 

  30. Harle CA, Harman JS, Yang S. Physician and patient characteristics associated with clinical inertia in blood pressure control. J Clin Hypertens. 2013;15:820–4. https://doi.org/10.1111/jch.12179.

    Article  Google Scholar 

  31. Wang Z, Wang X, Shen Y, Li S, Chen Z, Zheng C, et al. China Hypertension Survey Group: The Standardized Management of Hypertensive Employees Program. Effect of a workplace-based multicomponent intervention on hypertension control: a randomized clinical trial. JAMA Cardiol. 2020:1–9. https://doi.org/10.1001/jamacardio.2019.6161.

  32. Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens. 1998;16:971–5. https://doi.org/10.1097/00004872-199816070-00010.

    Article  CAS  PubMed  Google Scholar 

  33. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Soc Hypertens. 2018;12:579.e1–73. https://doi.org/10.1016/j.jash.2018.06.010.

    Article  Google Scholar 

  34. Mori H, Ukai H, Yamamoto H, Saitou S, Hirao K, Yamauchi M, et al. Current status of antihypertensive prescription and associated blood pressure control in Japan. Hypertens Res. 2006;29:143–51. https://doi.org/10.1291/hypres.29.143.

    Article  CAS  PubMed  Google Scholar 

  35. Hozawa A, Kuriyama S, Shimazu T, Ohmori-Matsuda K, Tsuji I. Seasonal variation in home blood pressure measurements and relation to outside temperature in Japan. Clin Exp Hypertens. 2011;33:153–8. https://doi.org/10.3109/10641963.2010.531841.

    Article  PubMed  Google Scholar 

  36. Ministry of Health, Labour and Welfare of Japan, National Federation of Health Insurance Societies of Japan. Data health planning guide (revised version). 2017. https://www.mhlw.go.jp/file/06-Seisakujouhou-12400000-Hokenkyoku/0000201969.pdf. Accessed Sep 20 2019.

Download references

Acknowledgements

The authors are deeply indebted to Dr. Shoji Tabata, the staff of Ishikawa-ken Health Service Association, and the staff of Foundation of General Incorporated Foundation Kinki Health Administration Center for their excellent support. We also thank all members of Heiwado Health Insurance Society and Heiwado Occupational Health Care Office, especially Ms. Atsuko Kawamura for her careful coordination of the staff administering the health checkups. We thank Analisa Avila, ELS, of Edanz Group (https://en-author-services.edanzgroup.com/) for editing a draft of this paper.

Funding

This study was partly supported by a Grant-in-Aid for Scientific Research (Grant number 17K17539) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Azusa Shima.

Ethics declarations

Conflict of interest

Three authors (AS, AM, and YK) are salaried employees of the retail company where the present study was conducted. The other authors declare no conflicts of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shima, A., Arima, H., Miura, K. et al. Cluster-randomized controlled trial for the early promotion of clinic visits for untreated hypertension. Hypertens Res 44, 355–362 (2021). https://doi.org/10.1038/s41440-020-00559-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-020-00559-0

Keyword

Search

Quick links